| TRADE NAME | MARKETING
COMPANY | PRE-/CLINICAL APPLICATION | COUNTRIES APPROVED IN |
| Photofrin | QLT Phototherapeutics | Oesophageal, lung, bladder and cervical dysplasia | Canada (1993), | The Netherlands (1994), | Japan (1994), | USA (1995), | France (1996), | Germany (1997), | Finland (1999), | UK (1999), | Sweden (2000), | Italy (2000), | Ireland (2000), | Poland (2000) |
| Levulan | DUSA Pharmaceuticals | Actinic keratosis
| USA (1999), | Actinic
keratosis and | Sweden (2001), | basal-cell carcinoma | Europe (2001) |
| Metvix | Photocure ASA | Actinic keratosis and
| Sweden (2001), | basal-cellcarcinoma | Europe (2001) |
| Visudyne | QLT Phototherapeutics | Wet-AMD | Europe (2001),
| USA (2000), | Canada
(2000), | Subfoveal choroidal neovascularisation | Europe (2001), | USA(2001), | Canada (2001) |
| ATMPn | GlaxoWellcome and Cytopharm |
Psorasis and non-melanoma
skin cancer | Germany (1997) |
| Purlytin | Miravant Medical Technologies |
Psorasis and restenosis | USA (1998) |
| Foscan | BioLitec Pharmaceuticals |
Head and neck cancers | Europe (2001) |
|
|